The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004
Abstract
BACKGROUND: Widespread use of pneumococcal conjugate vaccine (PCV7) resulted in decreases in invasive disease among children and elderly persons. The benefits may be offset by increases in disease due to serotypes not included in the vaccine (hereafter, "nonvaccine serotypes"). We evaluated the effect of PCV7 on incidence of disease due to nonvaccine serotypes. METHODS: Cases of invasive disease were identified in 8 geographic areas through the Centers for Disease Control and Prevention's Active Bacterial Core surveillance. Serotyping and susceptibility testing of isolates were performed. We calculated the incidence of disease for children aged <5 years and adults aged > or =65 years. We compared rates of serotype-specific disease before and after PCV7 was licensed for use. RESULTS: The annual incidence of disease due to nonvaccine serotypes increased from an average of 16.3 cases/100,000 population during prevaccine years (1998-1999) to 19.9 cases/100,000 population in 2004 for children aged <5 years (P=.01) and from 27.0 cases/100,000 population during prevaccine years to 29.8 cases/100,000 population in 2004 for adults aged > or =65 years (P=.05). Significant increases in the incidences of disease due to serotypes 3, 15, 19A, 22F, and 33F were observed among children during this period (P<.05 for each serotype); serotype 19A has become the predominant cause of invasive disease in children. The incidence of disease due to these serotypes also increased among elderly persons. CONCLUSIONS: The incidence of pneumococcal disease caused by nonvaccine serotypes is increasing. Ongoing surveillance is needed to monitor the magnitude of disease caused by nonvaccine serotypes, to ensure that future vaccines target the appropriate serotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Self-citationEfficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Eskola, J., Kilpi, T., Palmu, A., Jokinen, J., Eerola, M., Haapakoski, J., Herva, E., Takala, A., Käyhty, H., Karma, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440602 · Cited by 1,455
Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Self-citationLexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
Brueggemann, A. B., Griffiths, D. T., Meats, E., Peto, T., Crook, D. W., & Spratt, B. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374624 · Cited by 619
Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine
Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., & Klugman, K. P. (1999) · The Journal of Infectious Diseases · doi:10.1086/315009 · Cited by 515
(2005) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.294.16.2022 · Cited by 450
Kaplan, S. L., Mason, E. O., Wald, E. R., Schutze, G. E., Bradley, J. S., Tan, T. Q., Hoffman, J. A., Givner, L. B., Yogev, R., & Barson, W. J. (2004) · Pediatrics · doi:10.1542/peds.113.3.443 · Cited by 417
Dagan, R., Givon‐Lavi, N., Zamir, O., Sikuler‐Cohen, M., Guy, L., Janco, J., Yagupsky, P., & Fraser, D. (2002) · The Journal of Infectious Diseases · doi:10.1086/339525 · Cited by 339
Pai, R., Moore, M. R., Pilishvili, T., Gertz, R. E., Whitney, C. G., Beall, B., & Active Bacterial Core Surveillance Team (2005) · The Journal of Infectious Diseases · doi:10.1086/498043 · Cited by 330
Self-citation
Cited by
Pipkins, H. R., Bradshaw, J. L., Keller, L. E., Swiatlo, E., & McDaniel, L. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179159 · Cited by 1,338
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationEpidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
Global epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Self-citationPathogenesis, treatment, and prevention of pneumococcal pneumonia
van der Poll, T., & Opal, S. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61114-4 · Cited by 720
Huttner, B., Goossens, H., Verheij, T., & Harbarth, S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70305-6 · Cited by 574
Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Hsu, H. E., Shutt, K. A., Moore, M. R., Beall, B. W., Bennett, N. M., Craig, A. S., Farley, M. M., Jorgensen, J. H., Lexau, C. A., Petit, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0800836 · Cited by 497
Self-citationBalsells, E., Guillot, L., Nair, H., & Kyaw, M. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177113 · Cited by 393
Population genomics of post-vaccine changes in pneumococcal epidemiology
Croucher, N. J., Finkelstein, J. A., Pelton, S. I., Mitchell, P. K., Lee, G. M., Parkhill, J., Bentley, S. D., Hanage, W. P., & Lipsitch, M. (2013) · Nature Genetics · doi:10.1038/ng.2625 · Cited by 365
Davies, J. M., Lewis, M. P. N., Wimperis, J., Rafi, I., Ladhani, S., & Bolton‐Maggs, P. H. B. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08843.x · Cited by 341
Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence
Weinberger, D. M., Trzciński, K., Lu, Y.-J., Bogaert, D., Brandes, A., Galagan, J., Anderson, P. W., Malley, R., & Lipsitch, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000476 · Cited by 314
Harboe, Z. B., Dalby, T., Weinberger, D. M., Benfield, T., Mølbak, K., Slotved, H. C., Suppli, C. H., Konradsen, H. B., & Valentiner-Branth, P. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu524 · Cited by 313
Harboe, Z. B., Thomsen, R. W., Riis, A., Valentiner-Branth, P., Christensen, J. J., Lambertsen, L., Krogfelt, K. A., Konradsen, H. B., & Benfield, T. L. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000081 · Cited by 309
Healthcare utilization and cost of pneumococcal disease in the United States
Huang, S. S., Johnson, K. M., Ray, G. T., Wroe, P., Lieu, T. A., Moore, M. R., Zell, E. R., Linder, J. A., Grijalva, C. G., Metlay, J. P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.088 · Cited by 296
Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
Huang, S. S., Hinrichsen, V. L., Stevenson, A. E., Rifas-Shiman, S. L., Kleinman, K., Pelton, S. I., Lipsitch, M., Hanage, W. P., Lee, G. M., & Finkelstein, J. A. (2009) · Pediatrics · doi:10.1542/peds.2008-3099 · Cited by 269
Gladstone, R. A., Lo, S. W., Lees, J. A., Croucher, N. J., van Tonder, A. J., Corander, J., Page, A. J., Marttinen, P., Bentley, L. J., Ochoa, T. J., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.021 · Cited by 257
Trotter, C. L., & Maiden, M. C. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.48 · Cited by 203
Rudolf, I., Bakonyi, T., Šebesta, O., Mendel, J., Peško, J., Betášová, L., Blažejová, H., Venclíková, K., Straková, P., Nowotny, N., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.31.20867 · Cited by 65
Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants
Miyaji, E. N., Carvalho, E., Oliveira, M. L. S., Raw, I., & Ho, P. L. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500064 · Cited by 66
“Current pneumococcal conjugate vaccines are able to reduce both carriage and invasive disease caused by serotypes included in the formulations; however, the replacement of prevalent serotypes with non-vaccine serotypes has taken place and has led to reduced efficacy after some years of widespread use in children (59,6…”
BackgroundCasado-Flores, J., Rodrigo, C., Arístegui, J., Martínón, J. M., Fenoll, A., & Mendez, C. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817bd2dc · Cited by 47
Metadata
- Authors
- Hicks, L. A., Harrison, L. H., Flannery, B., Hadler, J. L., Schaffner, W., Craig, A. S., Jackson, D., Thomas, A., Beall, B., Lynfield, R., Reingold, A., Farley, M. M., Whitney, C. G., & Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11
- Volume
- 196
- Issue
- 9
- Pages
- 1346-1354
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2098218091
- Cited by
- 737
- References
- 25
- FWCI
- 53.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.